Trans Molecules Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Mandi, Himachal Pradesh, India, established in 2015.
2015 Mandi, Himachal Pradesh, India Struck Off
Last Updated:
Access Report
About Trans Molecules Pharma Private Limited

Trans Molecules Pharma Private Limited, a struck off private limited company, was established on 30 June 2015 in Mandi, Himachal Pradesh, India. Engaging in medicinal chemical & botanical products within the manufacturing sector, it holds CIN: U74999HP2015PTC000988. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

Its leadership includes Jagdish Kapoor (Director), Devanshu Kapoor (Director). Its latest AGM occurred on 29 September 2018, with the balance sheet filed on 31 March 2018. It is based at 167/8, Chobbatta Bazar, Mandi, Mandi, Himachal Pradesh, 175001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999HP2015PTC000988

  • Registration Number

    000988

  • Incorporation Date

    30 June 2015

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 7 Months
  • Last Filing with ROC 31 Mar 2018
  • Revenue Growth **** 37.47%
  • Ebitda **** 250.71%
  • Net Worth 7.46%
  • Total Assets **** 58.75%
Company report

Trans Molecules Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Trans Molecules Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Trans Molecules Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Jagdish Kapoor Director 30 Jun 2015 Current
Devanshu Kapoor Director 30 Jun 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Trans Molecules Pharma.

Trans Molecules Pharma Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 37.47% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth moved up by a moderate rise of 7.46%.

Trans Molecules Pharma revenue growth over time
Trans Molecules Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 37.47%
*******
*******
*******
*******
Revenue from Operations
*******
 37.47%
*******
*******
*******
*******
Total Assets
*******
 58.75%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
 7.46%
*******
*******
*******
*******
EBITDA
*******
 250.71%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Trans Molecules Pharma?

In 2017, Trans Molecules Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Trans Molecules Pharma?

Unlock and access historical data on people associated with Trans Molecules Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Trans Molecules Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trans Molecules Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Trans Molecules Pharma
Recent Activity within the Organization
  • Annual General Meeting

    The activity Trans Molecules Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records. was completed.

  • Balance Sheet

    The activity Trans Molecules Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Himachal Pradesh. was completed.

  • Director Appointment

    Progress on Jagdish Kapoor was appointed as a Director was appointed as a Director on 30 Jun 2015 & has been associated with this company since 10 years 7 months . was documented.

  • Director Appointment

    Progress on Devanshu Kapoor was appointed as a Director was appointed as a Director on 30 Jun 2015 & has been associated with this company since 10 years 7 months . was documented.

  • Company Incorporation

    Progress on Trans Molecules Pharma Private Limited was registered on 30 Jun 2015 with Roc Himachal Pradesh & aged 10 years 7 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Trans Molecules Pharma Private Limited?

The CIN of Trans Molecules Pharma Private Limited is U74999HP2015PTC000988.

Where is Trans Molecules Pharma Private Limited headquartered?

Trans Molecules Pharma Private Limited is headquartered at 167/8, Chobbatta Bazar, Mandi, Mandi, Himachal Pradesh, 175001.

When was Trans Molecules Pharma Private Limited incorporated?

Trans Molecules Pharma Private Limited was incorporated on 30 June 2015.

Who are the current directors of Trans Molecules Pharma Private Limited?

The current directors of Trans Molecules Pharma Private Limited are

What is the primary industry of Trans Molecules Pharma Private Limited?

The primary industry of Trans Molecules Pharma Private Limited is Manufacturing.

Is Trans Molecules Pharma Private Limited a listed company?

Trans Molecules Pharma Private Limited is unlisted.

What is the capital structure of Trans Molecules Pharma Private Limited?

The authorized capital of Trans Molecules Pharma Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available